.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Chubb
Mallinckrodt
Citi
UBS
Farmers Insurance
Chinese Patent Office
Boehringer Ingelheim
Cantor Fitzgerald
Covington

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084949

« Back to Dashboard
NDA 084949 describes MENEST, which is a drug marketed by Monarch Pharms and is included in four NDAs. It is available from three suppliers. Additional details are available on the MENEST profile page.

The generic ingredient in MENEST is estrogens, esterified. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estrogens, esterified profile page.

Summary for NDA: 084949

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 084949

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MENEST
estrogens, esterified
TABLET;ORAL 084949 ANDA Pfizer Laboratories Div Pfizer Inc 61570-075 61570-075-50 50 TABLET, FILM COATED in 1 BOTTLE (61570-075-50)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
US Department of Justice
Covington
Baxter
Cerilliant
Deloitte
McKinsey
Citi
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot